<DOC>
	<DOC>NCT00906126</DOC>
	<brief_summary>A phase I, open-label trial to determine a safe dose of oral misoprostol required to augment labor in nulliparous women diagnosed with arrest of dilation.</brief_summary>
	<brief_title>Oral Misoprostol for Labor Augmentation: A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Dilatation, Pathologic</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>nulliparous gestational age of at least 36 weeks singleton gestation cephalic presentation reassuring fetal heart rate 4 cm or greater cervical dilation ruptured membranes with clear amnionic fluid intrauterine pressure catheter in place less than 200 MVU's nonreassuring fetal heart rate meconiumstained amnionic fluid previous uterine incision maternal fever pregnancyinduced hypertension or other pregnancyrelated complications known fetal anomalies placenta previa or unexplained vaginal bleeding estimated fetal weight of 4,500 grams or greater evidence of cephalopelvic disproportion any moderate or severe preexisting disease contraindication to the use of prostaglandins</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>oral misoprostol</keyword>
	<keyword>labor augmentation</keyword>
	<keyword>arrest of dilation</keyword>
	<keyword>nulliparous</keyword>
</DOC>